This activity has expired. Credit is no longer available.
This activity is supported by independent educational grants from AstraZeneca and Bristol-Myers Squibb.
Non-Small Cell Lung Cancer
Whitney Lewis, PharmD, BCOP
The University of Texas MD Anderson Cancer Center
The role of immunotherapy in non–small cell lung cancer has been rapidly expanding as results from several clinical trials have come out in recent years. Takeaways from these studies and a differential diagnosis of a case study patient with anemia and nephritis demonstrate key points advanced practitioners should be aware of when managing this patient population.
|
|
These activities, certified for CME/CE/CPE credit, are jointly provided by
  |